Antimicrobial peptide LL-37 forms complex with bacterial DNA to facilitate blood translocation of bacterial DNA and aggravate ulcerative colitis.
Duan. Zilei Z; Fang. Yaqun Y; Sun. Yang Y; Luan. Ning N; Chen. Xue X; Chen. Mengrou M; Han. Yajun Y; Yin. Yizhu Y; Mwangi. James J; Niu. Junkun J; Wang. Kunhua K; Miao. Yinglei Y; Zhang. Zhiye Z; Lai. Ren R
Key Findings
- LL‑37 binds bacterial DNA, forming a complex that evades immune clearance.
- The LL‑37‑bacterial DNA complex is higher in the blood and gut lesions of ulcerative colitis patients.
- This complex activates TLR9 and drives Th1, Th2, and Th17 immune responses, increasing gut permeability and disease severity.
Practical Outcomes
- For self‑directed health optimizers, the take‑away is that boosting LL‑37 (e.g., via certain supplements or high‑intensity exercise) might backfire if gut bacteria are leaking DNA, potentially aggravating inflammation. Focus on supporting gut barrier integrity (e.g., with butyrate, zinc, glutamine) and limiting excess bacterial DNA exposure (good hygiene, balanced microbiome) rather than trying to increase LL‑37 levels indiscriminately.
Summary
The study found that the body’s own antimicrobial peptide LL‑37 can bind to bacterial DNA, turning the DNA into a “trojan horse” that slips into the bloodstream and worsens ulcerative colitis by triggering immune inflammation. This complex also makes the gut lining leakier, helping more bacterial DNA get into the blood.
Abstract
Bacterial DNA (bacDNA) is frequently found in serum of patient with ulcerative colitis (UC) and Crohn's disease, even blood bacterial culture is negative. How bacDNA evades immune elimination and is translocated into blood remain unclear. Here, we showed that bacDNA avoids elimination and disables bacteria-killing function of antimicrobial peptide LL-37 (Cramp in mice) by forming complex with LL-37, which is inducible after culture with bacteria or bacterial products. Elevated LL-37-bacDNA complex was found in plasma and lesions of patients with UC. LL-37-bacDNA promoted inflammation by inducing Th1, Th2 and Th17 differentiation and activating toll-like receptor-9 (TLR9). The complex also increased paracellular permeability, which possibly combines its inflammatory effects to promote local damage and bacDNA translocation into blood. Cramp-bacDNA aggravated mouse colitis severity while interference with the complex ameliorated the disease. The study identifies that inflammatogenic bacDNA utilizes LL-37 as a vehicle for blood translocation and to evade immune elimination. Additionally, bacteria may make a milieu by releasing bacDNA to utilize and resist host antimicrobial peptides as a 'trojan horse'.
Study Information
pubmed
2018
2018-09-22T00:00:00.000Z
10.1016/j.scib.2018.09.014